University of Illinois Urbana-Champaign

Porsche Financial Services strengthens leadership team

Retrieved on: 
Tuesday, April 2, 2024
Bugatti, Moses Austin, CRM, SVKM's NMIMS, University of Illinois Urbana-Champaign, Strategic management, Management information system, University, Business administration, Kellogg School, Temple University, Marketing communications, IPO, MBA, Northwestern University, Digital transformation, Northern Illinois University, Capital market, Term, Florida State University, BBA, PFS, Treasury, Customer service, Management

Atlanta, April 02, 2024 (GLOBE NEWSWIRE) -- Porsche Financial Services, Inc. (PFS) announced today the appointment of four new vice presidents to key leadership positions.

Key Points: 
  • Atlanta, April 02, 2024 (GLOBE NEWSWIRE) -- Porsche Financial Services, Inc. (PFS) announced today the appointment of four new vice presidents to key leadership positions.
  • "Following the Porsche IPO in September 2022, Porsche Financial Services has continued to evaluate how the organization can most effectively support its continued growth plan,” said Ross Dupper, President and CEO of Porsche Financial Services.
  • John Claiborne, VP Digital Transformation and Data Intelligence: John began his career with Porsche in 2001 as an IT contractor and has since held positions with increasing technical and management responsibility with Porsche Business Services, Porsche Cars North America, and Porsche Financial Services, where he managed the US launch of exclusive brand financial services for Bentley, Lamborghini, and Bugatti in 2012.
  • As the dedicated financial services company for Porsche Cars North America, PFS provides custom financial solutions and products to Porsche customers and dealers in the United States and Canada.

Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at ASIPP 2024

Retrieved on: 
Monday, April 8, 2024
Biotechnology, Men, Health, Consumer, Other Health, Pharmaceutical, Surgery, Other Science, Research, Medical Devices, Science, Women, Seniors, Clinical Trials, Week, Sciatica, LDH, Incidence, Ferring Pharmaceuticals, Patient, Spinal disc herniation, Șaeș, University, ESI, Quality of life, Manager, University of Illinois Urbana-Champaign, Society, Back pain, LSM, Pain, SAE

"Based on these findings, SI-6603 could provide another option where a single injection to the lumbar disc could offer patients significant relief from the unrelenting pain often associated with lumbar disc herniation."

Key Points: 
  • "Based on these findings, SI-6603 could provide another option where a single injection to the lumbar disc could offer patients significant relief from the unrelenting pain often associated with lumbar disc herniation."
  • An analysis assessing current treatment patterns and gaps in clinical management of patients with newly diagnosed LDH was also presented.
  • The analysis reviewed medical claims data of more than a million U.S. patients over a four-year period.
  • Among patients who received more than one ESI, one in five (22.4%) underwent surgery with 14.2% of those patients receiving repeated surgeries.

Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024

Retrieved on: 
Tuesday, March 19, 2024
Retina, University of Nevada, Reno, Houston Methodist Hospital, Webcast, Associate, ASX, KOL, University, Doctor of Philosophy, MBA, University of Illinois Urbana-Champaign, Shore, AMD, FACS, Medicine, Pharmaceutical industry

Additionally, Opthea will provide a strategic outlook.

Key Points: 
  • Additionally, Opthea will provide a strategic outlook.
  • A live question and answer session will follow the formal presentations.
  • To register for this live webcast, click here .
  • A replay of the webcast will be made available on the Company’s website.

Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors

Retrieved on: 
Tuesday, March 12, 2024
University of Illinois Urbana-Champaign, Drug discovery, Schering-Plough, Patient, Genentech, Acquisition, Cancer, Laboratory, Biology, Northern Illinois University, Stanford University, Amgen, Pharmaceutical industry

CAMBRIDGE, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced the appointment of Thomas J. Schall, Ph.D., former Chairman, CEO and Founder of ChemoCentryx before its acquisition by Amgen, to its Board of Directors.

Key Points: 
  • CAMBRIDGE, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced the appointment of Thomas J. Schall, Ph.D., former Chairman, CEO and Founder of ChemoCentryx before its acquisition by Amgen, to its Board of Directors.
  • “On behalf of the entire Immuneering team, we are honored to welcome Dr. Schall to our Board,” said Ben Zeskind, Chief Executive Officer, Immuneering Corporation.
  • From 1993 to 1997, Dr. Schall worked at the DNAX Research Institute, a division of Schering-Plough Corporation.
  • in biology from Northern Illinois University and his Ph.D. in cancer biology from Stanford University.

QT Imaging’s Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

Retrieved on: 
Thursday, March 14, 2024
Research, Medical Devices, Women, Engineering, Manufacturing, Radiology, Consumer, Health, Science, Oncology, ACT, NAC, Partnership, Patient, Champaign–Urbana metropolitan area, Sunnybrook Health Sciences Centre, Biomarker, University of Illinois Urbana-Champaign, Cancer, University, Doctor of Philosophy, Electricity, MD, Computer engineering, Risk, Woman, Breast cancer, Safety, Radiation, Bangladesh Technical Education Board, Radiation therapy, Grainger College of Engineering, Medical imaging

This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy (NAC).

Key Points: 
  • This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy (NAC).
  • As part of this grant, Breast Acoustic CT™ (ACT) quantitative images with independent biomarkers known to be sensitive to cancer will be collected, and the response of cancer to therapy, will be derived from quantitative ultrasound based on backscatter analysis.
  • This collaboration also addresses the ongoing clinical need in breast cancer therapy for the development of an inexpensive, robust, and accurate technique to identify the response, within weeks, of breast cancer to neoadjuvant chemotherapy.
  • The early identification of non-responders to NAC or any cancer treatment remains a highly significant medical problem and necessary for adaptive precision medicine.

Illinois Comptroller Susana Mendoza Honors SHENIX CEO Olga Camargo During Women's History Month

Retrieved on: 
Thursday, April 4, 2024
Land, University of Illinois Urbana-Champaign, Comptroller, Entrepreneurship, Woman, Women's History Month, Partner

CHICAGO, April 4, 2024 /PRNewswire-PRWeb/ -- The Illinois Office of Comptroller named Olga Camargo, CEO and founder of SHENIX, as a 2024 Women's History Month honoree during a ceremony hosted by Susana A. Mendoza on March 21 in Springfield. Designed specifically for Latinas, the SHENIX® app empowers Latinas to make informed financial decisions for themselves, their families, careers, businesses, and communities.

Key Points: 
  • The Illinois Office of Comptroller named Olga Camargo, CEO and founder of SHENIX, as a 2024 Women's History Month honoree during a ceremony hosted by Susana A. Mendoza on March 21 in Springfield.
  • CHICAGO, April 4, 2024 /PRNewswire-PRWeb/ -- The Illinois Office of Comptroller named Olga Camargo, CEO and founder of SHENIX, as a 2024 Women's History Month honoree during a ceremony hosted by Susana A. Mendoza on March 21 in Springfield.
  • Designed specifically for Latinas, the SHENIX® app empowers Latinas to make informed financial decisions for themselves, their families, careers, businesses, and communities.
  • During the monthlong celebration of Women's History Month in March, Mendoza's office recognized Camargo and several other women for their positive and significant contributions.

ILOE STUDIOS Elevates Midwest Apparel Market With Apparel Industry Veterans Francine Rich And Karen Bennett

Retrieved on: 
Monday, April 1, 2024
University of Illinois Urbana-Champaign, MART, University, Record, Woman, Film industry

CHICAGO, April 1, 2024 /PRNewswire/ -- ILOE STUDIOS, the internationally recognized womenswear and accessories trade show, welcomes Francine Rich as director of modern womenswear sales and Karen Bennett as director of contemporary sales. Both are widely considered among the most dynamic and effective apparel industry sales leaders with proven track records for maximizing exhibitors' presence at major trade shows in the U.S. Their moves to the ILOE STUDIOS team represent further elevation of the event's leadership team to deliver a customer-centric experience with unbeatable return on investment.

Key Points: 
  • Rich joins ILOE STUDIOS with over two decades of fashion industry experience, including sales leadership roles for better women's brands and in the management of trade shows such as Moda, WWDMagic/White, and Project Women's.
  • Rich will leverage her background to launch Studio Wear, a new venture for ILOE STUDIOS that expands the trade show's platform in women's fashion and accessories.
  • "We are delighted to welcome Francine and Karen to our team at this pivotal moment," said ILOE STUDIOS CEO Jeff Zuckerman.
  • Rich and Bennett join the ILOE STUDIOS vision for curating a high performing and relevant fashion hub in the Midwest.

THE PROSTATE CANCER FOUNDATION ANNOUNCES 2023 CHALLENGE AWARDS TOTALING MORE THAN $21 MILLION FOR PROSTATE CANCER RESEARCH

Retrieved on: 
Thursday, March 14, 2024
University of Illinois Urbana-Champaign, PCF, University of Sydney, Prostate cancer, Genetic testing, Immunotherapy, Prostate Cancer Foundation, Lund University, Oncogene, Patient, PET, Biomarker, Research, Aircraft pilot, University, Doctor of Philosophy, Biology, MBA, MPH, Johns Hopkins University, Institute of Cancer Research, CBP, University of Pretoria, PSMA, Medical imaging

LOS ANGELES, March 14, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research.

Key Points: 
  • LOS ANGELES, March 14, 2024 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the 2023 Class of PCF Team Challenge Award recipients and a total of more than $21 million in funding for innovative prostate cancer research.
  • PCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly innovative research with the greatest potential for accelerating new and improved treatments for advanced prostate cancer.
  • Following a rigorous peer review process that assessed each project's scientific merit and potential patient impact, 20 highly coveted PCF Challenge Awards totaling $21.3 million were granted to teams at some of the world's leading cancer research institutions.
  • (Evaluating the impact of treatment with darolutamide on age-related outcomes in vulnerable, older patients with metastatic hormone-sensitive prostate cancer.)

Governor JB Pritzker Announces Historic $500 Million Investment Aligning with the CHIPS and Science Act

Retrieved on: 
Monday, February 26, 2024
Public Policy, Government, Semiconductor, State, Local, Technology, Software, Artificial Intelligence, Hardware, CHIPS, Civic, Engineering, Senior, Artificial intelligence, Investment, Commerce, University, CSU, Corporation, IBM Fellow, Silicon, SVP, University of Chicago, Innovation Hub, Federation, University of Illinois Urbana-Champaign, Ecosystem, Chamber of commerce, Environment, Partnership, UIUC, Chicago State University, NSTC, Provost, Fermilab, Physics, Black, Illinois Institute of Technology, Research, Innovation, Inflation, Economic development, Discovery Partners Institute, IBM, Infrastructure, National Science Foundation, Renewable energy

Innovate Illinois Chair and Governor JB Pritzker announced a groundbreaking proposal to allocate $500 million towards the advancement of beyond silicon quantum technology in the state.

Key Points: 
  • Innovate Illinois Chair and Governor JB Pritzker announced a groundbreaking proposal to allocate $500 million towards the advancement of beyond silicon quantum technology in the state.
  • "We were already solidifying our position as a top hub for quantum development, we're ready to leap ahead.
  • Ensuring we make timely, strategic investments and demonstrate unwavering commitment builds confidence among private industry and the federal government," said Governor JB Pritzker.
  • Governor Pritzker has been fostering the innovation environment in Illinois and this announcement will uplift these efforts.

InScribe Alongside A Guest Panel Receives Student Support and Success Best-in-Track Award at OLC Innovate

Retrieved on: 
Thursday, March 7, 2024
New Mexico Highlands University, Teaching, University, Success, University of Illinois Urbana-Champaign, Provost, University of Pittsburgh, Entrepreneurship, Compulsory figures, Fort Hays, Faculty, Student, Fort Hays State University, Knowledge, Gies College of Business, Education

DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- InScribe Education is delighted to share our achievement alongside a distinguished guest panel in receiving the Best-in-Track Award for Student Support and Success at the OLC Innovate 2023 conference. This accolade celebrates the most impactful presentations, as chosen by conference attendees.

Key Points: 
  • The Best-in-Track Award for Student Support and Success at OLC Innovate 2023 was awarded to InScribe for their timely session on fostering a sense of belonging for online learners.
  • DENVER, March 7, 2024 /PRNewswire-PRWeb/ -- InScribe Education is delighted to share our achievement alongside a distinguished guest panel in receiving the Best-in-Track Award for Student Support and Success at the OLC Innovate 2023 conference .
  • InScribe warmly congratulates our panelists and appreciates their vital contributions to this session.
  • On behalf of the entire panel, InScribe extends our gratitude to the OLC for recognizing our hard work, innovation, and dedication to improving the online learning experience.